ChromaTan, Inc
Bradford Olson has a diverse work experience in various roles and industries. Bradford started their career as a Student Engineer at the United States Nuclear Regulatory Commission in 2010, where they assembled, reviewed, and summarized operational and management documents. Bradford then worked as an Undergraduate/Graduate Research Assistant at the Wind Tunnel/Aero Research Lab from 2011 to 2013.
In 2013, Olson joined the Advance Composite Materials Textiles Research Lab as a Graduate Research Assistant, where they worked until 2014. Bradford continued their research at the same lab as a Graduate Research Assistant from 2014 to 2019.
Olson's most recent position was at Chromatan, Inc, where they started as a Mechanical Engineer II in December 2018. In this role, they designed microfluidic devices utilizing Dean's Vortices for particle separation and developed methods for manufacturing microfluidic devices using various 3D printers. Bradford also managed a group of 2 to 3 engineers, utilized LabVIEW programs for testing, and analyzed separation results using software such as Image J and Matlab. Bradford was also a co-author of a successful NIIMBL Phase 1 proposal.
In January 2022, Olson was promoted to the position of Senior Mechanical Engineer at Chromatan, Inc. The end date for this role is not specified, indicating that they are currently still employed in this position.
Bradford Olson has a Bachelor's degree in Mechanical Engineering with a Minor in Psychology from the University of Massachusetts Lowell, which they obtained from 2008 to 2012. Bradford then pursued a Master's degree in Mechanical Engineering with a concentration in Fluids/Composite Materials at the same institution from 2013 to 2014. Bradford further advanced their education by earning a Doctor of Philosophy (PhD) degree in Mechanical Engineering with a concentration in Fluids/Composite Materials as well, which they completed from 2014 to 2017 at the University of Massachusetts Lowell.
This person is not in any teams
This person is not in any offices
ChromaTan, Inc
ChromaTan is solving a major process bottleneck in therapeutic protein production while significantly lowering the cost of goods for biotech and contract manufacturing companies. Our CCTC platform provides an inexpensive column-free, continuous, and single-use solution that will replace large scale column chromatography processes used in biologicsmanufacturing. The platform has been through extensive beta testing with over a dozen of major biotech companies and has consistently shown a 5-15X increase in throughput at an equivalent or better product quality.